Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 61
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Intensive Care Med ; 33(3): 538-41, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17235510

RESUMEN

BACKGROUND: Ornithine alpha-ketoglutarate (OKG) has proved to be efficient in restoring glutamine (Gln) pools which are strongly depleted in hypercatabolic patients. Since its two components, alpha-ketoglutarate (alphaKG) and ornithine (Orn), give rise to glutamate (Glu), they are both considered as Gln precursors. The aim of this study was to assess the relative contributions of Orn and alphaKG to Gln generation in a rat model of burn injury. METHODS: Forty-eight young Wistar rats were scalded to give a 20% burn surface area. They were fasted for 24 h and then refed by enteral nutrition for 48 h by gavages with Osmolite (Abbott-Ross, 210 kcal/kg day(-1), 1.18 N/kg day(-1)) supplemented with either 5 g OKG/kg day(-1) (B-OKG), Orn (isomolar to OKG; B-Orn), alphaKG (isomolar to OKG; B-KG) or glycine (as an isonitrogenous control; B-Gly). Rats in the B-KG group also received glycine to make all the groups isonitrogenous. Amino acid concentrations were determined in plasma, muscles, jejunal mucosa and liver. RESULTS: The alpha-KG-enriched diet had no effect on plasma Glu content or plasma and muscle Gln content compared with the burn-injured controls. The Orn-enriched diet significantly increased (p<0.01) muscle Glu and Gln contents but not plasma Gln content. In OKG-treated animals, plasma Gln as well as muscle Glu and Gln were significantly higher than in the control (p<0.01), alpha-KG-treated (p< 0.01) and Orn-treated (p<0.05 for muscle Gln and p<0.01 for plasma Gln) animals. CONCLUSION: OKG was more efficient than Orn or alphaKG alone in restoring Gln pools in plasma and muscle, which is evidence of metabolic interaction between the two components of this molecule.


Asunto(s)
Quemaduras/terapia , Nutrición Enteral , Glutamina/efectos de los fármacos , Ácidos Cetoglutáricos/farmacología , Ornitina/análogos & derivados , Aminoácidos/metabolismo , Análisis de Varianza , Animales , Combinación de Medicamentos , Sinergismo Farmacológico , Glutamina/metabolismo , Mucosa Intestinal/metabolismo , Ácidos Cetoglutáricos/administración & dosificación , Hígado/metabolismo , Masculino , Músculo Esquelético/metabolismo , Ornitina/administración & dosificación , Ornitina/farmacología , Distribución Aleatoria , Ratas , Ratas Wistar , Distribución Tisular
2.
Gastroenterology ; 119(6): 1496-505, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11113071

RESUMEN

BACKGROUND & AIMS: No blood marker assessing the functional absorptive bowel length has been identified. Plasma citrulline, a nonprotein amino acid produced by intestinal mucosa, is one candidate. We tested this hypothesis in adult patients with the short-bowel syndrome, whose condition can lead to intestinal failure. METHODS: In 57 patients, after a minimal follow-up of 2 years subsequent to final digestive circuit modification, postabsorptive citrulline concentration was measured and parenteral nutrition dependence was used to define permanent (n = 37) and transient (n = 20) intestinal failure. Absorptive function, studied over a 3-day period, was evaluated by net digestive absorption for protein and fat (n = 51). Relations between quantitative values were assessed by linear regression analysis and cutoff citrulline threshold, for a diagnosis of intestinal failure by linear discriminant analysis. Cox model was used to compare citrulline threshold and anatomic variables of the short bowel as indicators of transient as opposed to permanent intestinal failure. RESULTS: In patients with short-bowel syndrome, citrulline levels were lower than in controls (n = 51): 20 +/- 13 vs. 40 +/- 10 micromol/L (mean +/- SD), respectively (P < 0.001). After multivariate analysis, citrullinemia was correlated to small bowel length (P < 0.0001, r = 0.86) and to net digestive absorption of fat, but to neither body mass index nor creatinine clearance. A 20-micromol/L threshold citrullinemia, (1) classified short bowel patients with permanent intestinal failure with high sensitivity (92%), specificity (90%), positive predictive value (95%), and negative value (86%); and (2) was a more reliable indicator (odds ratio, 20.0; 95% confidence interval, 1.9-206.1) than anatomic variables (odds ratio, 2.9; 95% confidence interval, 0. 5-15.8) to separate transient as opposed to permanent intestinal failure. CONCLUSIONS: In patients with short-bowel syndrome, postabsorptive plasma citrulline concentration is a marker of functional absorptive bowel length and, past the 2-year adaptive period, a powerful independent indicator allowing distinction of transient from permanent intestinal failure.


Asunto(s)
Citrulina/sangre , Ingestión de Alimentos/fisiología , Enterocitos/patología , Mucosa Intestinal/metabolismo , Intestinos/patología , Síndrome del Intestino Corto/metabolismo , Síndrome del Intestino Corto/patología , Absorción , Adulto , Anciano , Biomarcadores/sangre , Femenino , Humanos , Masculino , Persona de Mediana Edad , Concentración Osmolar , Valor Predictivo de las Pruebas , Valores de Referencia , Sensibilidad y Especificidad
3.
J Nutr ; 130(12): 2897-902, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11110843

RESUMEN

The efficacy of ornithine alpha-ketoglutarate (OKG) in preventing bacterial translocation and dissemination, metabolic disorders and changes in mucosal enzyme activities was assessed in a model of bacterial translocation in rats. Antibiotic decontamination was performed 4 d before intragastric inoculation with an Escherichia coli strain (10(10) bacteria/kg body). Two days later, the rats were given either a lipopolysaccharide (LPS) 0127:B8 or a saline injection and were deprived of food for 24 h. Enteral nutrition, [Osmolite, 880 kJ/(kg. d)] supplemented with either OKG (LPS + OKG) or glycine (Saline + Gly or LPS + Gly), was then given for 2 d. Urinary total nitrogen losses and 3-methylhistidine excretion were determined daily. On killing at d 3, bacterial translocation to the mesenteric lymph nodes (MLN) and dissemination to the spleen and liver were evaluated, jejunal mucosa enzyme activities were assayed and tissue free amino acids in muscles were measured. Endotoxin induced translocation from the gut lumen to the MLN in all groups, whereas dissemination occurred only in LPS-treated rats. OKG significantly reduced dissemination of the bacteria in the spleen. 3-Methylhistidine excretion was greater in the LPS + Gly group (+25%, P: < 0.05) than in either the LPS + OKG or Saline + Gly group. The group fed the OKG-enriched diet had higher muscular glutamine, ornithine and arginine concentrations than did the Gly-supplemented groups (P: < 0.05). Intestinal sucrase and aminopeptidase activities were higher in the LPS + OKG group than in the LPS + Gly group (-30%, P: < 0.05). OKG supplementation limits bacterial dissemination and metabolic changes after injury in rats and thus may be useful in the prevention of gut-derived sepsis in critically ill patients.


Asunto(s)
Traslocación Bacteriana , Endotoxemia/metabolismo , Infecciones por Escherichia coli/metabolismo , Escherichia coli/fisiología , Ornitina/análogos & derivados , Ornitina/uso terapéutico , Animales , Traslocación Bacteriana/efectos de los fármacos , Endotoxemia/tratamiento farmacológico , Endotoxemia/microbiología , Nutrición Enteral , Escherichia coli/efectos de los fármacos , Infecciones por Escherichia coli/tratamiento farmacológico , Infecciones por Escherichia coli/microbiología , Glicina , Mucosa Intestinal/enzimología , Yeyuno/efectos de los fármacos , Yeyuno/enzimología , Lipopolisacáridos , Hígado/microbiología , Ganglios Linfáticos/microbiología , Masculino , Mesenterio/microbiología , Metilhistidinas/orina , Músculos/metabolismo , Nitrógeno/orina , Ornitina/administración & dosificación , Ratas , Ratas Wistar , Bazo/microbiología
4.
J Gastroenterol Hepatol ; 15(10): 1199-204, 2000 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11106102

RESUMEN

BACKGROUND: One process identified as detrimental in liver preservation is proteolysis. METHODS: We tested the effects of adding antiproteolytic amino acids (L-alanine, L-glutamine, L-histidine, L-leucine, L-methionine, L-phenylalanine, L-proline, L-tryptophan) to the preservation medium, in a model of reperfusion of 24 h cold-stored rat livers. RESULTS: During the preservation period, antiproteolytic amino acids inhibited the proteolysis observed in stored livers as shown by branched-chain amino acid fluxes, which switched from release to uptake. During reperfusion, cold storage of lives without the addition of antiproteolytic amino acids resulted in a decrease in the total amino acid and branched-chain amino acid uptake and a lower perfusion flow rate. The addition of antiproteolytic amino acids during liver storage resulted in the maintenance of total amino acid and branched-chain amino acid uptake and a significant improvement in the perfusion flow rate during reperfusion. CONCLUSIONS: The presence of antiproteolytic amino acids in the preservation medium might be of interest in improving hepatic graft viability in transplantation.


Asunto(s)
Aminoácidos/administración & dosificación , Trasplante de Hígado , Hígado/metabolismo , Soluciones Preservantes de Órganos , Preservación de Órganos/métodos , Aminoácidos/farmacología , Animales , Frío , Interpretación Estadística de Datos , Hidrólisis , Técnicas In Vitro , Hígado/efectos de los fármacos , Masculino , Modelos Biológicos , Perfusión , Proteínas/metabolismo , Ratas , Ratas Sprague-Dawley , Reperfusión , Factores de Tiempo
5.
Crit Care Med ; 28(6): 1772-6, 2000 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10890617

RESUMEN

OBJECTIVE: To compare the effectiveness on wound healing time in severe burn patients of ornithine alpha-ketoglutarate supplementation of enteral feeding vs. an isonitrogenous control. Previous clinical and experimental studies suggest a beneficial effect of enterally administered ornithine alpha-ketoglutarate supplementation on protein metabolism in burn patients, but few data deal with clinical outcome. DESIGN: Prospective double-blind randomized trial. SETTING: Burn treatment center of an army hospital. PATIENTS: Forty-seven severe burn patients with total burned body surface areas of 25% to 95% and presence of full thickness burn who were prescribed early exclusive enteral nutrition. Either ornithine alpha-ketoglutarate or isonitrogenous control (soy protein mixture, Protil-1) were administered twice a day as a bolus (2 x 10 g) at 9 am and 9 pm for 3 wks. The patients were evaluated for wound healing time (primary end point), antibiotic use, tolerance, duration of enteral nutrition, and nutritional status. INTERVENTIONS: Serial blood samples were collected in each patient for determination of serum transthyretin and plasma phenylalanine, and urine sampling was performed for determination of 3-methylhistidine excretion at day 4 and day 21 after burn injury. MEASUREMENTS AND MAIN RESULTS: Wound healing times in patients receiving ornithine alpha-ketoglutarate or Protil-1 were 60 +/- 7 and 90 +/- 12 days, respectively (p < .05) for similar grafted surfaces. Based on increased serum transthyretin concentrations, both groups showed an improvement of nutritional status at day 21 after burn. Taking a cut-off value of 110 unit burn standard for severity of injury, plasma phenylalanine concentrations, and urinary 3-methylhistidine/creatinine ratio were significantly reduced (p < .05) in the less severe burn patients (<110 unit burn standard) supplemented with ornithine alpha-ketoglutarate. CONCLUSIONS: Ornithine alpha-ketoglutarate supplementation of enteral feeding significantly shortens wound healing time in severe burn patients. In addition, ornithine alpha-ketoglutarate administration was safe and well tolerated and decreased protein hypercatabolism in the less severe burn patients.


Asunto(s)
Quemaduras/tratamiento farmacológico , Nutrición Enteral , Ornitina/análogos & derivados , Proteínas de Soja/uso terapéutico , Cicatrización de Heridas/efectos de los fármacos , Adulto , Método Doble Ciego , Femenino , Humanos , Puntaje de Gravedad del Traumatismo , Masculino , Ornitina/uso terapéutico , Estudios Prospectivos
6.
Crit Care Med ; 27(8): 1511-6, 1999 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10470758

RESUMEN

OBJECTIVE: To study the pathogenesis of the host response during bacterial translocation, a rat model was designed for prolonged follow-up after injury. DESIGN: A prospective, controlled animal study. SETTING: Animal laboratory. SUBJECTS: Young male Wistar rats. INTERVENTIONS: Antibiotic decontamination of rats was performed 4 days before intragastric inoculation with a selected Escherichia coli strain (10(10) bacteria/kg of body weight). Two days later, the rats received a lipopolysaccharide injection or not (control group) and were observed for 3 days. They were then killed. A reference group (pair-fed healthy animals) was studied in parallel. MEASUREMENTS AND MAIN RESULTS: During observations, urinary total nitrogen loss and 3-methylhistidine excretion were determined daily. When the rats were killed, mesenteric lymph nodes (MLNs), spleen, and liver were aseptically removed and cultured. Colonies identified as translocated E. coli were counted in each organ. Intracellular amino acid free pools were measured in extensor digitorum longus and anterior tibialis. Endotoxin induces bacterial translocation of bacteria from gut lumen to MLNs (100% vs. 59% in the lipopolysaccharide-untreated control group; p < .05) and dissemination to spleen and liver (65% and 45% of positive cultures after endotoxemia, respectively, vs. 6% and 12% in the control groups). No translocation occurred in the reference group. Evidence for the hypermetabolic response was seen in lipopolysaccharide-treated and infected rats, but protein catabolism was more closely related to the occurrence of bacterial dissemination to spleen and liver than to translocation alone (e.g., the cumulative 3-methylhistidine excretion during the observation period was 4.07+/-0.18 micromol in uninfected rats, 4.48+/-0.29 in rats with positive MLN cultures alone and 6.17+/-0.30 in MLN, spleen, or liver infected rats; 1 vs. 2, NS; 3 vs. 1, and 3 vs. 2, p < .05). CONCLUSIONS: Gut barrier failure is associated with a deep excessive catabolic response in the host. The mechanism by which the metabolic state affects the resistance to infection apparently involves amino acid metabolism.


Asunto(s)
Traslocación Bacteriana/fisiología , Modelos Animales de Enfermedad , Endotoxemia/metabolismo , Endotoxemia/microbiología , Infecciones por Escherichia coli/metabolismo , Infecciones por Escherichia coli/microbiología , Animales , Endotoxemia/patología , Infecciones por Escherichia coli/patología , Hígado/microbiología , Hígado/patología , Ganglios Linfáticos/microbiología , Masculino , Mesenterio/microbiología , Nitrógeno/orina , Tamaño de los Órganos , Estudios Prospectivos , Proteínas/metabolismo , Distribución Aleatoria , Ratas , Ratas Wistar , Bazo/microbiología , Bazo/patología , Timo/microbiología , Timo/patología , Factores de Tiempo
7.
Clin Nutr ; 18(1): 29-33, 1999 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10459079

RESUMEN

BACKGROUND: Glutamine is considered an essential nutrient for cellular growth. AIM: To test the suitability of alpha-ketoisocaproyl-Gln (Kic-Gln) as a new glutamine (Gln) precursor to sustain human fibroblast growth. METHODS: [3H] thymidine uptake into cellular DNA of human fibroblasts. Extracellular and intracellular amino acid patterns were determined with peptides and acylated compounds. RESULTS: L-alanyl-L-glutamine (used here as a recognized Gln precursor) promoted DNA synthesis, while N-acetyl-L-glutamine (used here as a negative control since it is known to be a poor Gln precursor) and alpha-ketoisocaproyl-glutamine had no effect. Alanyl-glutamine progressively gave rise to free glutamine in the growth medium. In contrast, glutamine supplied in acylated form was poorly available and did not appear in free form in the medium. In addition, only alanyl-glutamine increased intracellular glutamine and glutamate levels. In contrast, Kic-Gln was able to sustain net protein synthesis as judged by total protein content and reduced intracellular levels of most essential amino acids. CONCLUSION: Kic-Gln appears to be a poor extra-cellular precursor of Gln to sustain cell growth.


Asunto(s)
Fibroblastos/metabolismo , Glutamina/análogos & derivados , Glutamina/farmacología , Disponibilidad Biológica , Células Cultivadas , ADN/biosíntesis , Dipéptidos/metabolismo , Dipéptidos/farmacología , Femenino , Glutamina/metabolismo , Humanos , Biosíntesis de Proteínas , Timidina/metabolismo
8.
J Hepatol ; 30(5): 843-9, 1999 May.
Artículo en Inglés | MEDLINE | ID: mdl-10365811

RESUMEN

BACKGROUND/AIMS: Conflicting data on the effects of amino acids on biliary function led us to investigate their interaction with taurocholate in the perfused rat liver model. METHODS: To investigate the influence of amino acids on the bile acid-independent component of bile flow, 12 livers were perfused with (n = 6) and without (n = 6) amino acid addition from t30 min. For the study of bile acid-dependent bile flow, 24 livers were perfused under 8 experimental conditions according to the perfusate taurocholate concentration (12.5, 25, 37.5 or 50 microM) and whether amino acids were or were not added from t30 min. RESULTS: In the absence of taurocholate, amino acids induced a 40% (p<0.01) decrease in bile flow together with an increase in hepatic water content (17.8%, p< 0.05). Thus, amino acids exert an inhibitory effect on bile acid-independent bile flow despite the postulated cell swelling-dependent increase in bile flow. When livers were perfused at various taurocholate concentrations, amino acids induced, in addition to their inhibitory effect on bile acid-independent bile flow, a significant increase in taurocholate apparent choleretic activity (13.2 microl/micromol vs. 10.6 microl/micromol; p = 0.05), while taurocholate intrinsic clearance was significantly decreased (4.5+/-1.2 ml x min(-1) x g(-1) vs. 6.1+/-1.3 ml x min(-1) x g(-1); p<0.01). CONCLUSIONS: These data suggest that at physiological bile acid concentrations amino acids exert an inhibitory effect on both bile acid-dependent and- independent bile flow, whereas at higher taurocholate concentrations this inhibitory effect disappears, probably because of cell swelling-dependent mechanisms.


Asunto(s)
Aminoácidos/farmacología , Ácidos y Sales Biliares/farmacología , Bilis/metabolismo , Hígado/fisiología , Ácido Taurocólico/farmacología , Animales , Bilis/efectos de los fármacos , Agua Corporal/metabolismo , Relación Dosis-Respuesta a Droga , Técnicas In Vitro , Cinética , Hígado/efectos de los fármacos , Masculino , Perfusión , Ratas , Ratas Sprague-Dawley
9.
Nutrition ; 15(5): 379-83, 1999 May.
Artículo en Inglés | MEDLINE | ID: mdl-10355851

RESUMEN

The effect of ornithine alpha-ketoglutarate (OKG) on cytochrome P-450 enzyme activities was studied in a well-defined model of injury (burn followed by fasting then subsequent hypocaloric diet) administered to young rats for 3 d. Hepatic microsomes were prepared by ultracentrifugation and levels of cytochromes P-450 were determined spectrophotometrically. The activities of ethoxy-resorufin-O-deethylase (EROD), benzyloxy-resorufin-O-dealkylase (BROD), and erythromycin demethylase were measured as markers of P-450 1A, 2A, and 3A isotypes respectively. The level of total hepatic microsomal proteins (8 mg/mL) remained constant. The level of cytochrome P-450 (1.14+/-0.08 nmol/mg microsomal proteins) was decreased by a hypocaloric diet (23%, P = 0.003) and burn further enhanced this phenomenon (15%, P = 0.03). Both healthy and burned rats receiving OKG showed the same level of cytochrome P-450 as the rats fed ad libitum. OKG supplementation counteracted the enhancement (40%) of EROD activity induced by hypocaloric diet but did not influence BROD and erythromycin demethylase activities. OKG sustained cytochrome P-450 levels in rats fed a hypocaloric diet, even after burning. These findings indicate that OKG may favor drug metabolism in this injured population.


Asunto(s)
Hidrocarburo de Aril Hidroxilasas , Quemaduras/tratamiento farmacológico , Quemaduras/enzimología , Sistema Enzimático del Citocromo P-450/metabolismo , Microsomas Hepáticos/enzimología , Ornitina/análogos & derivados , Animales , Citocromo P-450 CYP1A1/metabolismo , Citocromo P-450 CYP2B1/metabolismo , Citocromo P-450 CYP3A , Ingestión de Energía , Masculino , Ornitina/uso terapéutico , Oxidorreductasas N-Desmetilantes/metabolismo , Ratas , Ratas Sprague-Dawley
10.
Metabolism ; 48(2): 190-3, 1999 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10024080

RESUMEN

We investigated the role of the nitric oxide (NO) synthase (NOS) pathway in muscular metabolism during endotoxemia in four groups of male Wistar rats. Two groups were injected with the lipopolysaccharide (LPS) of Escherichia coli (3 mg/kg), with one group treated using N(G)-nitro-L-arginine methylester ([L-NAME] 85 mg/kg/d) and the other not. The two control groups included one treated with L-NAME and the other not. After 24 hours of fasting, the rats were fed by controlled enteral nutrition and killed on day 3. The results showed that (1) NOS inhibition was detrimental during endotoxemia, increasing lethality from 20% to 80.5%, and (2) NOS inhibition did not modify the hypercatabolic state consecutive to endotoxemia, particularly at the muscular level (nitrogen balance, total-body and muscular weight loss, and muscular protein and glutamine concentrations). However, myofibrillar catabolism was delayed in the LPS-NAME group. In conclusion, NO production is of major importance for survival after an endotoxemic challenge, but contributes weakly to the metabolic response of muscle to injury.


Asunto(s)
Arginina/metabolismo , Endotoxemia/metabolismo , Músculo Esquelético/metabolismo , Óxido Nítrico/metabolismo , Animales , Peso Corporal/fisiología , Inhibidores Enzimáticos/farmacología , Ácido Glutámico/metabolismo , Masculino , Proteínas Musculares/metabolismo , Miofibrillas/metabolismo , NG-Nitroarginina Metil Éster/farmacología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa/metabolismo , Nitrógeno/orina , Ratas , Ratas Wistar
11.
Metabolism ; 47(11): 1366-71, 1998 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9826214

RESUMEN

Ornithine alpha-ketoglutarate (OKG) has been advocated in the treatment of critically ill patients for its anabolic effect on protein metabolism. Since OKG is a precursor of glutamine, arginine, and polyamines, key substrates of intestinal metabolism and function, we investigated the influence of OKG on intestinal adaptation and trophicity and on glutamine status after small bowel resection. After massive (80%) small bowel resection, rats were enterally fed for 7 days with a standard diet supplemented with either OKG (2 g/kg/d) or an isonitrogenous amount of glycine. OKG induced an adaptative hyperplasia of the villi, demonstrated in the jejunum by an increase in the villus height to crypt depth ratio (OKG v control, 4.3+/-0.4 v 3.3+/-0.5, P < .01) along with an increase (P < .05) in ornithine decarboxylase (ODC) activity (+80%) and ornithine content (+102%). Plasma glutamine (+25%) and muscle glutamine (anterior tibialis [AT], +43%; extensor digitorum longus [EDL], +54%) and protein (AT, +32%) were significantly higher (P < .05) after OKG administration, supporting its role in the restoration of glutamine pools. In summary, enterally administered OKG, which enhances intestinal adaptation after massive resection and improves muscle glutamine and protein content, could contribute significantly to nutritional management after small bowel resection.


Asunto(s)
Adaptación Fisiológica/efectos de los fármacos , Intestino Delgado/efectos de los fármacos , Ornitina/análogos & derivados , Aminoácidos/sangre , Aminoácidos/metabolismo , Animales , Nutrición Enteral , Mucosa Intestinal/efectos de los fármacos , Intestino Delgado/fisiología , Intestino Delgado/cirugía , Masculino , Músculos/metabolismo , Ornitina/administración & dosificación , Ornitina/farmacología , Proteínas/metabolismo , Ratas , Ratas Wistar
13.
J Nutr ; 128(3): 563-9, 1998 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-9482764

RESUMEN

To investigate appropriate mode and daily dose of enteral ornithine alpha-ketoglutarate (OKG) administration, 54 burn patients (total burn surface area: 20-50%) were included in a randomized controlled trial and assigned to receive either a supplement of OKG (10, 20 or 30 g/d) as bolus or continuous infusion, or a continuous infusion of an isonitrogenous amount of a soy protein mixture (Protil-1: 10, 20 or 30 g/d) in addition to their enteral diet. The influence of these treatments on clinical outcome and biological indices was evaluated. OKG administration significantly improved nitrogen balance and reduced 3-methylhistidine and hydroxyproline urinary elimination. This was associated with a gradual rise in plasma glutamine over time. Given as a bolus, OKG significantly improved wound healing, assessed both clinically [day of last graft: (mean +/- SEM) OKG bolus 23.7 +/- 2.1 d versus Protil-1, 39.9 +/- 9.9 d; P < 0.05] and by hydroxyproline excretion, and biological markers of nitrogen metabolism, and tended to reduce duration of enteral nutrition (P = 0.12). The higher catabolic status in the patients administered 20 g OKG/d at the onset of the study, despite randomization, precludes any definite conclusion (concerning the dose-effect relationship). However, based on 3-methylhistidine elimination, our data indicate a benefit of 30 g OKG/d administration over 10 g/d. This study further supports OKG supplementation in burn patients. In addition, this is the first trial based on objective data that favors bolus over continuous infusion of OKG in critically ill patients.


Asunto(s)
Quemaduras/tratamiento farmacológico , Ornitina/análogos & derivados , Adulto , Relación Dosis-Respuesta a Droga , Nutrición Enteral , Humanos , Bombas de Infusión , Masculino , Persona de Mediana Edad , Ornitina/administración & dosificación , Ornitina/uso terapéutico , Proteínas de Soja/administración & dosificación , Proteínas de Soja/uso terapéutico , Resultado del Tratamiento
14.
Eur Surg Res ; 30(1): 69-76, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9493697

RESUMEN

Intestinal permeability can be assessed by measuring urinary mannitol and lactulose excretion after oral administration. This test may be useful as a tool in experimental studies to explore the effects of specific diets intended to promote the repair of the integrity of the gut barrier. In this study we standardized the lactulose-mannitol test in rats and applied it to a burned-rat model. The conditions were: oral administration of an isotonic mixture of 50 mg of mannitol and 66 mg of lactulose, followed by aseptic collection of urine over 4 h. The increase in the lactulose/mannitol ratio in burned rats was due to higher lactulose excretion. These results corroborate those obtained in burn patients and show that our model is suitable for further experiments on nutritional manipulation.


Asunto(s)
Quemaduras/metabolismo , Mucosa Intestinal/metabolismo , Lactulosa/orina , Manitol/orina , Animales , Permeabilidad , Ratas , Ratas Wistar
15.
Am J Clin Nutr ; 67(1): 124-8, 1998 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9440386

RESUMEN

The specific effect of the molecular form of the nitrogen supply (oligopeptides and whole proteins) on amino acid kinetics during enteral feeding after surgery has not been assessed previously. In a prospective, randomized study, patients having undergone esophagectomy or gastrectomy for cancer received jejunal infusions of oligopeptide-based or whole-protein-based complete formulas (OPD and WPD, respectively) during two 9-h periods on 2 consecutive days in a crossover design. The OPD and WPD had identical energy compositions and amino acid profiles. Amino acid peripheral bioavailability (measurements of area under the curve of arterial blood concentrations), amino acid arteriovenous differences, and insulin and glucagon responses were measured. Amino acid peripheral bioavailability was higher (leucine: 54%, P < 0.01; essential amino acids: 48%, P < 0.01; total amino acids: 53%, P < 0.02) and peripheral appearance of amino acids was more homogeneous (variation around the calculated plateau of plasma leucine was 39% for OPD and 78% for WPD, P < 0.001) with the OPD than with the WPD. With the OPD, insulin stimulation was faster and plasma concentrations of leucine and insulin were correlated (r = 0.77, P < 0.01). The OPD led to a higher amino acid peripheral bioavailability than the corresponding WPD. These results could be useful for a better definition of clinical indications of semi-elemental diets.


Asunto(s)
Abdomen/cirugía , Aminoácidos/sangre , Nutrición Enteral/métodos , Alimentos Formulados , Leucina/sangre , Oligopéptidos/farmacocinética , Adulto , Anciano , Aminoácidos/farmacocinética , Disponibilidad Biológica , Estudios Cruzados , Método Doble Ciego , Femenino , Humanos , Insulina/sangre , Insulina/metabolismo , Leucina/metabolismo , Modelos Lineales , Masculino , Persona de Mediana Edad , Oligopéptidos/administración & dosificación , Estudios Prospectivos , Factores de Tiempo
17.
Clin Chem ; 43(8 Pt 1): 1421-8, 1997 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9267323

RESUMEN

The Hitachi L-8500A is a newly available apparatus for amino acid (AA) analysis that allows automatic on-line mixing of the ninhydrin reagent. The within-run precision (human plasma pools at three different concentrations) showed CVs < 3.8% except for the lowest concentration of citrulline (4.4%), Tyr (4.5%), and alpha-aminobutyric acid (7.6%), and for the intermediate concentration of Asp (8.7%). Between-run precision (CV) was < 3.1% for 17 AAs and < 8.0% for 24 of 25 AAs (CV Asp = 12.0%). For retention times, within-run precision was < 0.4% and between-run precision < 1.8%. Excellent relations were found between the results from the Hitachi L-8500A and the widely used Beckman 6300 analyzer (0.929 < or = r < or = 0.999). The detection was still linear at 5 mumol/L except for Pro and hydroxyproline (20 mumol/L). The upper limit was at least 2500 mumol/L for 13 AAs and at least 1000 mumol/L for 27 of 29 AAs (anserine = 500, Val = 600 mumol/L). Values from 100 human plasma samples agreed with previously published data. We conclude that the results obtained with the Hitachi L-8500A are satisfactory when compared with those of other AA analyzers utilizing the same method. Furthermore, the Hitachi L-8500A displays several advantages including programming flexibility, microsample capacity, low noise plotting, ammonia filtering, and manual repacking of the analytical column.


Asunto(s)
Aminoácidos/análisis , Líquidos Corporales/química , Cromatografía por Intercambio Iónico/métodos , Aminoácidos/sangre , Automatización , Tampones (Química) , Calibración , Cromatografía Líquida de Alta Presión , Cromatografía por Intercambio Iónico/instrumentación , Estudios de Evaluación como Asunto , Humanos , Hidroxiprolina/análisis , Hidroxiprolina/sangre , Ninhidrina , Prolina/análisis , Prolina/sangre , Análisis de Regresión , Reproducibilidad de los Resultados , Sensibilidad y Especificidad
18.
Nutrition ; 13(4): 319-26, 1997 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9178282

RESUMEN

Lipid peroxidation index and antioxidant indicators were assessed by biochemical means in 193 healthy elderly volunteers (103 men and 90 women), ages 70-89 y and living freely in the Paris area. Lipid peroxidation index was in the same range as in young adults. Zinc, copper, and selenium levels were satisfactory and similar to those in young adults, though the range of copper values tended to be higher. Copper and selenium levels were higher in elderly women than in men. However, for selenium values this sex-related difference disappeared in elderly volunteers > 75 y. Copper-zinc-superoxide dismutase and glutathione peroxidase activities were similar to those in young adults, with no influence of sex or age. Vitamin E and total carotene, closely related to cholesterol levels, were satisfactory. Our findings show that markers of oxidative stress are not influenced by old age when good health and nutritional status are preserved, as in this selected population.


Asunto(s)
Biomarcadores , Peroxidación de Lípido , Estrés Oxidativo , Aptitud Física , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Cobre/sangre , Femenino , Glutatión Peroxidasa/sangre , Humanos , Lipoproteínas LDL/sangre , Masculino , Persona de Mediana Edad , Paris , Valores de Referencia , Selenio/sangre , Caracteres Sexuales , Superóxido Dismutasa/sangre , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Zinc/sangre
19.
Crit Care Med ; 25(2): 293-8, 1997 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9034267

RESUMEN

OBJECTIVES: Ornithine alpha-ketoglutarate has proved to be an efficient nutritional support in trauma situations, especially after burn injury. To determine whether the action of ornithine alpha-ketoglutarate is due to its alpha-ketoglutarate moiety (as a glutamine precursor), we studied the effects of alpha-ketoglutarate administered to rats as ornithine alpha-ketoglutarate, or in combination with arginine salt (arginine alpha-ketoglutarate), as the two closely related amino acids have similar metabolic behavior. DESIGN: Prospective, randomized trial. SETTING: Animal laboratory. SUBJECTS: Forty-six male Wistar rats, weighing approximately 90 g. INTERVENTIONS: Rats were burned over 20% of their body surface area, starved for 24 hrs, with water ad libitum, and then enterally refed for 48 hrs using Osmolite (210 kcal/kg/day, 1.2 g of nitrogen/kg/day), supplemented with one of the following: a) an amount of glycine isonitrogenous to ornithine alpha-ketoglutarate (group 1); b) 5 g of monohydrated ornithine alpha-ketoglutarate/kg/day (group 2); c) an amount of arginine alpha-ketoglutarate isonitrogenous to ornithine alpha-ketoglutarate (group 3); or d) an amount of arginine alpha-ketoglutarate isomolar to ornithine alpha-ketoglutarate (group 4). MEASUREMENTS AND MAIN RESULTS: We measured amino acid concentrations in plasma, muscle, and liver, and plasma urea concentration. At refeeding, ornithine alpha-ketoglutarate increased plasma glutamine concentration (p < .05 vs. the three other groups), and counteracted the increase in plasma phenylalanine concentration. In muscle, although the three alpha-ketoglutarate combinations induced similar increases in the glutamate pool, ornithine alpha-ketoglutarate induced the highest increase in glutamine (7.0 +/- 0.3 vs. 5.4 +/- 0.3 micromol/g in group 3, 6.3 +/- 0.3 in group 4, and 4.6 +/- 0.2 in group 1, p < .01 between group 2 and groups 3 or 1). Also, only ornithine alpha-ketoglutarate increased liver glutamine concentration. Finally, isomolar arginine alpha-ketoglutarate increased plasma urea concentration (+50% vs. the three other groups, p < .01). CONCLUSIONS: Our results demonstrate, for the first time, the following: a) the action of ornithine alpha-ketoglutarate as a glutamine precursor cannot solely be ascribed to alpha-ketoglutarate since arginine alpha-ketoglutarate combinations did not exhibit this effect to the same extent; and b) the action of ornithine alpha-ketoglutarate is not due to its nitrogen content since isonitrogenous arginine alpha-ketoglutarate did not reproduce the effects of ornithine alpha-ketoglutarate.


Asunto(s)
Aminoácidos/sangre , Quemaduras/metabolismo , Glutamina/metabolismo , Ácidos Cetoglutáricos/farmacología , Ornitina/análogos & derivados , Animales , Arginina/metabolismo , Peso Corporal/efectos de los fármacos , Nutrición Enteral , Ácidos Cetoglutáricos/metabolismo , Hígado/metabolismo , Masculino , Ornitina/metabolismo , Ornitina/farmacología , Ratas , Ratas Wistar
20.
Am J Clin Nutr ; 65(2): 512-8, 1997 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9022538

RESUMEN

Ornithine alpha-ketoglutarate (OKG) has been successfully used as an enteral supplement in the treatment of catabolic states, including burn injury. However, specific questions remain unanswered concerning burn patients, including OKG metabolism and metabolite production, appropriate mode of administration, and dose. We thus performed a kinetic study and followed plasma ornithine and OKG metabolite concentrations on day 7 postburn in 42 (35 men, 7 women) consecutive burn patients aged 33 +/- 2 y with a mean (+/-SEM) total burn surface area (TBSA) of 31 +/- 1%. Patients were randomly assigned to receive OKG as a single bolus (10 g; n = 13) or in the form of a continuous gastric infusion (10, 20, or 30 g/d over 21 h; n = 13) or an isonitrogenous control (n = 16). Plasma pharmacokinetics of ornithine followed a one-compartment model with first-order input (r = 0.993, P < 0.005). OKG was extensively metabolized in these patients (absorption constant = 0.028 min-1, elimination half-life = 89 min), with the production of glutamine, arginine, and proline; proline was quantitatively the main metabolite [in OKG bolus, area under the curve (AUC)0-7h: proline, 41.4 +/- 5.6 mmol.min/L; glutamine, 20.4 +/- 5.7 mmol.min/L; and arginine, 7.3 +/- 1.9 mmol.min/L]. Proline production was dose-dependent and quantitatively similar between modes of OKG administration. Glutamine and arginine production were not dose-dependent and were higher in the bolus group than in the infusion group. Overall, the bolus mode of OKG administration appeared to be associated with higher metabolite production compared with continuous infusion in burn patients, especially for glutamine and arginine.


Asunto(s)
Quemaduras/metabolismo , Ornitina/análogos & derivados , Ornitina/sangre , Ornitina/farmacocinética , Adulto , Arginina/sangre , Nutrición Enteral , Femenino , Semivida , Humanos , Infusiones Parenterales , Masculino , Ornitina/administración & dosificación , Ornitina/metabolismo , Distribución Aleatoria
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA